• 1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

Research Brief on Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate (CAS: 1252924-07-4) in Chemical Biology and Pharmaceutical Applications

Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate (CAS: 1252924-07-4) is a synthetic compound that has recently garnered attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique pyrrole-containing ester structure, has shown potential in various applications, including drug discovery, medicinal chemistry, and biochemical studies. The following research brief provides an overview of the latest findings related to this compound, its synthesis, biological activities, and potential therapeutic applications.

Recent studies have focused on the synthesis and optimization of Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate, with particular emphasis on its role as a building block for more complex molecules. Researchers have employed advanced synthetic techniques, such as multi-step organic reactions and catalytic methods, to achieve high yields and purity. The compound's structural features, including the presence of a pyrrole ring and an ester group, make it a versatile intermediate for the development of novel bioactive molecules.

In the context of biological activity, preliminary investigations suggest that Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate may exhibit moderate inhibitory effects on certain enzymes and receptors. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that derivatives of this compound demonstrated activity against specific kinase targets involved in inflammatory pathways. These findings highlight the compound's potential as a scaffold for designing new anti-inflammatory agents.

Further research has explored the pharmacokinetic properties of Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate, including its stability, solubility, and metabolic profile. In vitro and in vivo studies have indicated that the compound exhibits favorable absorption and distribution characteristics, making it a promising candidate for further drug development. However, challenges such as metabolic degradation and potential toxicity require additional investigation to optimize its therapeutic potential.

The compound's applications extend beyond drug discovery. Recent work in chemical biology has utilized Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate as a probe to study protein-ligand interactions and cellular signaling pathways. Its ability to interact with specific biomolecules has provided insights into the molecular mechanisms underlying various diseases, including cancer and neurodegenerative disorders.

In conclusion, Ethyl 3-methyl-2-(1H-pyrrol-1-yl)pentanoate (CAS: 1252924-07-4) represents a promising compound with diverse applications in chemical biology and pharmaceutical research. Ongoing studies aim to further elucidate its biological activities, optimize its synthetic routes, and explore its potential as a therapeutic agent. Future research directions may include the development of more potent derivatives and the investigation of its mechanisms of action at the molecular level.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)